Safilo Group S.p.A. (LON: 0NJ5)
London
· Delayed Price · Currency is GBP · Price in EUR
1.286
0.00 (0.00%)
Jul 19, 2022, 4:45 PM BST
Safilo Group Revenue
Safilo Group had revenue of 531.96M EUR in the half year ending June 30, 2024, a decrease of -6.82%. This brings the company's revenue in the last twelve months to 1.01B, down -4.68% year-over-year. In the year 2023, Safilo Group had annual revenue of 1.02B, down -4.83%.
Revenue (ttm)
1.01B EUR
Revenue Growth
-4.68%
P/S Ratio
n/a
Revenue / Employee
262.94K EUR
Employees
3,828
Market Cap
342.61M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.02B | -52.01M | -4.83% |
Dec 31, 2022 | 1.08B | 107.16M | 11.05% |
Dec 31, 2021 | 969.58M | 189.29M | 24.26% |
Dec 31, 2020 | 780.30M | -158.74M | -16.90% |
Dec 31, 2019 | 939.04M | 28.30M | 3.11% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |